Electra Therapeutics director and OrbiMed keep buying shares as the price slides
Electra Therapeutics director Carl Gordon and OrbiMed Advisors reported buying 92,116 shares, about $0.7 million, traded on November 6, 9 and 10 and filed on November 10.
The purchases
2 insiders
Purchase on Nov 10, filed on Nov 10
2
Buyers
$1.49M
Bought
0
Sellers
Director
OL
Orbimed Advisors LLC
Buy · $744.53k · 92,116 shares
+1.8%
CG
Carl L Gordon
Buy · $744.53k · 92,116 shares
+1.8%
On the right, by how much each one increased the number of shares they own. Purchases declared to the SEC, the US stock market watchdog (Form 4), decided on the spot and not scheduled in advance.
AI analysis
Nov 10
With TrueWallet Pro
Why these purchases matter given where the stock stands, and what they do not say. Upgrade to Pro from the TrueWallet app.